Comparable downregulation of trophoblast cell surface antigen 2 (TROP-2) has also been detected in triple-negative breast cancer (TNBC) cells exposed to TROP-2-targeted ADCs[13]. The gene discussed is TACSTD2; the disease is triple-negative breast carcinoma.